Jump to content

All content

Showing all content.

To sort the content by type, date or tags you will need to be logged into the hub. Join the hub today to enjoy full member benefits.

This stream auto-updates

  1. Past hour
  2. News Article
    A comprehensive programme of webinars has been unveiled for Clinical Audit Awareness Week 2026 (#CAAW26), including NHS England Chief Executive Sir James Mackey newly confirmed as a keynote speaker. Taking place from 22 to 26 June 2026, the annual campaign run by Healthcare Quality Improvement Partnership (HQIP) promotes the role of clinical audit and evidence-based improvement in improving patient care and outcomes. The centrepiece of the campaign is a series of free, online webinars spanning five themed days, each examining a different dimension of clinical audit and healthcare improvement. Opening on Monday 22 June, the first session will explore how clinical audit supports major NHS strategic priorities, including the three shifts outlined in the NHS 10‑Year Plan towards prevention, community‑based care and greater use of data and digital tools. Tuesday’s programme shifts the focus to patient and public involvement, with discussions on how engagement at local and national levels can address inequalities and improve outcomes, including a dedicated session on maternity care disparities. Midweek, the spotlight turns to innovation and transformation, highlighting how emerging tools and technologies are reshaping audit and improvement practices across healthcare systems. On Thursday, a webinar delivered in partnership with Patient Safety Learning will examine patient safety, demonstrating how robust audit data can identify risks, reduce harm and support safer care pathways. The week concludes on Friday with a focus on data‑informed improvement and impact, exploring how evidence from audits and registries can be translated into tangible, real‑world changes in care delivery. Across the week, sessions will also be complemented by daily announcements of the Excellence in Clinical Audit Awards, recognising achievements and best practice from across the sector. Winners will be presenting their projects to inspire others and share this excellent work. All webinars are free to attend, though advance registration is required. The programme is aimed at a wide audience, including clinicians, audit professionals, quality improvement specialists and healthcare leaders interested in leveraging data to improve care. By bringing together expertise from across the NHS and beyond, HQIP hopes the week will not only celebrate achievements but also build momentum for future improvement efforts. Discover the full programme, including the speakers and topics for each webinar: Clinical Audit Awareness Week, 22-26 June 2026
  3. News Article
    Cancer centres in nearly every region of England reported significant rises in recruitment freezes to oncology posts over the past year, according to new figures shared with HSJ. The Royal College of Radiologists’ president Stephen Harden warned that the growing constraints highlighted by the college’s research came at a time when cancer performance had stagnated – and that the NHS “desperately needed [more staff] to turn this round”. An exclusive regional breakdown calculated by the RCR based on its annual oncology workforce census, and shared with HSJ, found every region apart from two reported rises in the number of centres implementing recruitment freezes for oncology posts in 2025. The RCR’s Dr Harden said: “We completely get that we’re in a financially constrained environment but now is really not the time to be limiting recruitment to cancer posts, particularly around diagnosis and treatment. “Extra staff are desperately needed to turn this thing around. Waiting a month for your scan results – and longer – is not really what we should be about”. Read full story (paywalled) Source: HSJ, 18 June 2026
  4. Today
  5. Event
    until
    When organisations begin exploring healthcare interoperability, the conversation often starts with: “Which API should we use?” In reality, that is usually one of the last questions to ask. Successful interoperability starts with understanding: What data is required Who needs access to it When it is needed across the patient journey Whether the requirement is national, regional or local How information should be shared between systems and organisations. Only once these questions are answered can you determine the most appropriate integration pathway. For those already working in interoperability, standards and digital transformation, this webinar will move beyond the basics. It will explore the practical challenges organisations face when translating information sharing requirements into usable solutions. It will discuss: • National versus local integration approaches • Interoperability and integration readiness • NHS onboarding, governance and assurance considerations • Selecting the right integration route for your use case. Register
  6. Content Article
    We talk about resilience, efficiency, and ‘just getting through the day’. But behind closed doors, many GPs are working at a pace and intensity that is simply not safe. Many who have felt pushed to the brink: overwhelmed, burnt out, and questioning whether they can continue. That isn’t just a few isolated GPs; the data suggests this feeling is widespread across the profession. In Nottinghamshire, the local medical committee developed a safe working charter to support this shift in thinking. It’s not a prescriptive checklist, but it offers practical ways practices can start to embed safer ways of working. It focuses on two key areas: workload control and practice systems.
  7. News Article
    Britons are facing some of the “most severe” shortages of NHS medicines on record including common painkillers, epilepsy drugs and HRT, health leaders have warned, even forcing some patients with impaired digestive systems to skip meals. The National Pharmacy Association (NPA) has warned that medicine shortages pose a “serious risk to patient safety”. The Royal College of GPs has also raised concerns about the impact medicine shortages have on patients, GPs and pharmacists. Both have highlighted long-lasting supply issues affecting Estradot, a hormone replacement therapy (HRT) for menopausal women, and Creon, a drug taken by people with pancreatic cancer and cystic fibrosis to help them digest food. Britons are facing some of the “most severe” shortages of NHS medicines on record including common painkillers, epilepsy drugs and HRT, health leaders have warned, even forcing some patients with impaired digestive systems to skip meals. Olivier Picard, a pharmacist who chairs the NPA, said: “Medicine shortages are becoming more frequent, lasting longer and causing increasing disruption for patients.” “These shortages are some of the most severe the UK has experienced. It is deeply distressing to find patients who have travelled from pharmacy to pharmacy to find the medicines they need without success.” He said shortages were “frustrating and worrying”, and that “in some instances they pose a serious risk to patient safety”. Read full story Source: The Guardian, 18 June 2026 Further reading on the hub: Medicines shortages: minimising the impact on patients Creon shortages: “It’s just another thing patients with cystic fibrosis could do without” Medication supply issues: Mast cell activation syndrome (MCAS) Medication supply issues: A pharmacist’s perspective
  8. Content Article
    This report shares learning gained through examination of a regional care pathway – that is, a pathway of assessment and care for patients with a particular health condition – during a Health Services Safety Investigations Body (HSSIB) rapid response investigation pilot. The investigation aimed to investigate safety concerns shared with HSSIB about the safety and effectiveness of a care pathway that spanned multiple organisations and where specialist services were centralised to a single site. The pathway had been redesigned with engagement from the organisations, the public and staff to reduce inequalities. It was intended to improve patient outcomes and ensure efficient use of resources across the region. The investigation provided insights into how the governance of care pathways, including oversight and risk management, is achieved, and how cultural and communication challenges between organisations impacted on patients receiving appropriate care. The investigation identified differences between how the redesigned pathway was expected to operate and how it worked in practice. These differences affected staff wellbeing and led to concerns about risks to patient safety, including delays in access to specialist care. The learning in this report is shared to support organisations and integrated care boards (ICBs) to adopt effective change management processes that are informed by patient safety considerations when designing, implementing and overseeing care pathways. Findings A cross-organisation implementation board oversaw the redesign and initial implementation of the care pathway. Support and oversight from the ICB was time limited, ending before the project had been fully implemented, which impacted on the operationalisation of the service. A business case for implementation of the pathway was approved but not fully realised. This created expectations for how the pathway would operate that were not met in practice. There was no shared view across organisations about what the redesigned pathway could offer patients in reality. This limited the organisations’ ability to understand the risks across the pathway and to mitigate them to as low as reasonably practicable. There was no single guidance document shared between organisations, and there were inconsistencies in the documentation used to support decision making about whether patients should be provided with specialist care. Organisations held different perceptions of the risks to patient safety created by the redesign of the pathway. This impacted on clinical decision making and led to disagreements between teams. Organisational oversight of the pathway after its implementation was limited due to disengagement among staff and the absence of a collaboratively agreed evaluation plan. The data collected about the care pathway differed across organisations and was not routinely shared between them. This led to a difference in understanding about how the care pathway was working in practice and where improvements could be made. The ICB had limited ability to support ongoing improvement of the care pathway and had limited access to information about the quality and safety of the pathway in practice. Differences in the perceived purpose of the pathway led to barriers to collaborative learning and improvement of the pathway. These included examples of incivility among staff, which is known to impact on staff wellbeing and patient outcomes. HSSIB suggests safety learning for integrated care boards Safety learning for integrated care boards ICB/2026/019: HSSIB suggests that integrated care boards proactively identify the impact of commissioning decisions on pathways prior to implementation and develop mitigations to reduce any potential impacts on patient safety and equitable access to care. Safety learning for integrated care boards ICB/2026/020: HSSIB suggests that integrated care boards support organisations to effectively evaluate the implementation of new care pathways. Local-level learning prompts HSSIB investigations include local-level learning where this may help organisations and staff identify and think about how to respond to specific patient safety concerns at the local level. HSSIB has developed the following prompts to support local-level learning for NHS trusts when collaborating with other organisations across a regional care pathway. Safe implementation of the care pathway How do you identify and resource dedicated support to implement new care pathways? How do you ensure appropriate tools and resources are used to support the design and implementation of the care pathway? How do you identify and mitigate unexpected challenges to patient safety arising from the care pathway’s implementation? How do you identify and mitigate any mismatch between the expectations of patients, families, carers or staff and what the pathway can deliver in practice? How do you ensure that implementation of a care pathway is effectively evaluated to improve safety and learning? How do you identify and mitigate potential harm caused when implementing a new care pathway? The care pathway in practice How do you identify and manage incivility between staff across different organisations? How do you facilitate shared learning opportunities for staff across different organisations? How do you ensure information and documentation used to support the care pathway are aligned across different organisations? How do you enable staff to understand the context in which the care pathway may work in different organisations? How do you engage staff to understand the different requirements for electronic systems that may exist across the care pathway? How do you support interoperability of electronic systems to enable effective information sharing across different organisations? How do you enable new technology to be adopted and used across different organisations? How do you consider relevant tools and guidance when developing work processes across different organisations? Oversight of the care pathway How do you ensure shared governance forums are appropriately established and resourced, and are effective? How do you ensure concerns about the care pathway are escalated and acted on by senior and executive leadership teams across different organisations and the integrated care board? How do you ensure consistency in how data is collected and shared across different organisations, including with integrated care boards? How do you ensure that risks to the care pathway are identified and mitigated to as low as reasonably practicable across different organisations? How do you ensure messages about the care pathway are effectively shared and understood by staff across different organisations? How do you identify and facilitate proactive communication with a point of contact at the integrated care board with oversight of the care pathway?
  9. News Article
    A new resource to support adults at risk of self‑harm or suicide was launched in May at The University of Manchester’s Whitworth Art Gallery, at an event hosted by the NIHR Greater Manchester Patient Safety Research Collaboration. Jay’s Personalised Safety Planning Toolkit is a co‑designed set of materials created with researchers, people with lived experience of suicide and self‑harm, and healthcare professionals. It offers a more personalised approach to safety planning within health and care settings, supporting meaningful conversations around self‑harm and suicide. Inspired by the family of Jaymie Mart, known as Jay, who died by suicide in 2012 at the age of 32, the toolkit – which was funded by the National Institute for Health and Care Research (NIHR) – offers clear, practical guidance to help adults create and review personalised safety plans. Jay’s mother, Paula Mart, has played a key role in shaping the research, sharing her experiences to help improve support for people during times of acute mental health crisis and to prevent deaths by suicide. She said: “The toolkit helps as a guide in understanding and setting up an individualised safety plan for people in difficult times. They can help to change a mindset during times of crisis, that will hopefully keep them safe until they can get help, if needed, from family, friends or mental health professionals.” When describing the new resource, Katherine McGleenan, nurse consultant in suicide prevention research and lead of Jay’s study, said: “We know suicide can be prevented, however often people don’t know how to help or where to find support, for themselves or others. We can all make a difference, whatever role we are in. Jay’s toolkit is a powerful resource to help increase understanding, skills and confidence of how to support personalised safety planning. It might help someone who’s struggling and could potentially save lives.” Read full story Source: NIHR Greater Manchester Patient Safety Research Collaboration, 15 June 2026
  10. News Article
    The human papillomavirus (HPV) vaccine has already saved an estimated 200 lives from cervical cancer in England, with this figure projected to rise significantly as more people receive the jab, new data suggests. Research spearheaded by Queen Mary University of London and funded by Cancer Research UK indicates the HPV vaccine is proving highly effective in eliminating cervical cancer nationwide. The study estimates that children vaccinated at 12-13 years old face a near-zero risk of dying from the disease before turning 30. Crucially, England recorded no cervical cancer deaths among women aged 20 to 24 between 2020 and 2024 – a historic first. The study, published in The Lancet medical journal, also found that from 2015-19 there was an 80% reduction in cervical cancer deaths among women aged 20-24. However, despite progress towards eliminating cervical cancer, experts are worried about falling vaccination rates. Michelle Mitchell, chief executive of Cancer Research UK, said: “We know the HPV vaccine is extremely effective at stopping cervical cancer before it starts and for the first time, these findings show it is saving lives – a powerful example of what’s possible when science is backed by strong public health programmes. “Thanks to HPV vaccination and cervical screening, a future where almost nobody gets cervical cancer is now firmly in sight. “But uptake of the vaccine has dropped in recent years, and this progress is at risk. “It’s essential that the UK government and health systems urgently address this with targeted action to reach communities where uptake is the lowest. “Beating cervical cancer means beating it for everyone.“Every parent and guardian can support this by making sure children and young people get the HPV vaccine. “It’s also important that people take up cervical screening when invited, even if they have had the HPV vaccine.” Read full story Source: The Independent, 18 June 2026
  11. News Article
    Current inquiries into care failures lack teeth, and such a gap could be filled by a public inquiry, the government’s new national maternity adviser has revealed. Michelle Welsh’s comments at a Medical Journalists’ Association event on Wednesday came with two major investigations by Donna Ockenden and Baroness Amos due to report over the next fortnight. Ms Welsh also called for a review of regulatory authorities such as the General Medical Council, Care Quality Commission and the Nursing and Midwifery Council. She said this comment was in her capacity as Sherwood Forest MP, not as government adviser. Appointed by former health and social care secretary Wes Streeting last month, Ms Welsh said she wants to respect Ms Ockenden’s upcoming review into Nottingham University Hospitals and seek thoughts from families and staff once it is published on 24 June. However, she warned: “There is a gap, and that gap is that Donna Ockenden’s inquiry [in Nottingham cannot] legally make people talk.” She added: “The [Nottingham] inquiry is fundamentally about things that happened while [people] were in charge in very, very senior positions and making the decision, yet they can personally decide that they are not going to engage in it. “I think it should be an open book, and I am in conversations with the [Department of Health and Social Care] about a public inquiry.” She said the current regulatory system was failing families, and called on the government to appoint a maternity “commissioner”. Read full story (paywalled) Source: HSJ, 17 June 2026
  12. News Article
    The Medicines and Healthcare products Regulatory Agency (MHRA) has announced plans to launch a new AI regulatory sandbox aimed at improving medicines safety and accelerating the development of new treatments. The initiative, unveiled by Science Minister Lord Vallance on 9 June 2026, will provide companies and researchers with a controlled environment to test AI tools designed to predict how medicines may perform in people and identify potential safety risks earlier in the development process. Through the sandbox, the MHRA will work with industry and academic partners to assess whether AI can improve medicines safety assessment and identify risks that traditional methods may miss. Unlike the AI Airlock programme, which focuses on AI medical devices, the new sandbox will support the testing of AI tools used in medicines development and safety assessment. Up to five AI technologies will be tested during the first phase of the programme, with work due to begin in summer 2026. Lawrence Tallon, chief executive at the MHRA, said: “We’re seeing extraordinary advances in AI and biomedical science. The opportunity now is to harness them to deliver real benefits for patients. “These technologies could help us understand medicines better, generate stronger evidence on their safety, and accelerate the development of innovative treatments, especially in areas of unmet need. “For patients, that means greater confidence that the medicines they rely on are supported by the best available science, with evidence that better reflects the diverse range of people they are intended to treat.” Read full story Source: Digital Health, 16 June 2026
  13. Yesterday
  14. Article Comment
    Interesting article to highlight - as it does very well - the real-life consequences of disinformation and of underfunding healthcare treatments we might take for granted, such as vaccinations.
  15. Community Post
    Dear Sue, Thank you sue for this to discuss. Of course there are many PICC related thrombosis in our trust too. There is no such guideline that could be prevented. Definitely proper PICC line care, regular flushing with heparin and monitoring of PICC arm (DVT sign and symptoms) practices will minimise the risk but can not prevent the clot. We record as PICC related HAT.
  16. Event
    What does good consent look like in practice, and what are the patient safety consequences when patients are not truly informed? Join Radar Healthcare's webinar, Digital consent: How to deliver safer outcomes by bringing consent, risk and insight together, to explore the vital link between patient education, informed decision-making and safer care. Featuring perspectives from the Patients Association, Patient Information Forum, legal experts and frontline clinicians, this CPD-certified session will examine how organisations can strengthen consent processes, reduce risk and improve patient outcomes through better communication, education and insight. Register
  17. News Article
    A charity will invest £250m over the next three to five years in a government-backed scheme testing a new funding model for neighbourhood health. Macmillan Cancer Support has partnered with West Hertfordshire Teaching Hospitals Trust, non-profit enterprise Social Finance and the government’s Office for the Impact Economy to help other systems raise money from non-NHS sources. The intention is that investors who want to use their money for social purposes will add to the £250m, and will earn a return over an extended period, as the schemes reduce secondary healthcare demand. The “trailblazer” programme will choose six areas to develop more integrated and preventative care in the community, the organisations are due to announce today. The programme builds on a £10m initiative launched last year in West Hertfordshire, with the same partners, to improve care for older people with multiple conditions. In each area, the organisations will run a nine-month programme with financial and technical expertise, to design their model and build skills, confidence and culture to help attract “impact investment” finance. Read full story (paywalled) Source: HSJ, 17 June 2026
  18. News Article
    The Department of Health and Social Care wants tech suppliers to take on more financial risk by agreeing to new contract models aimed at improving value, HSJ understands. Tech industry figures have told HSJ that government officials have started asking suppliers on NHS contracts to take part of their payment once productivity gains have materialised. This would see a company paid some or all of its fee once the trust had realised some of the efficiency savings that were promised in the business case. Some consultancies are paid in this way, but it is not common with tech procurements. One senior industry figure said: “I understand the logic, if technology is being funded on the basis of productivity, suppliers are asked to share some of the delivery risk.” However, they added this would be “difficult” for suppliers, as “technology is only one part of whether benefits are realised”. They told HSJ: “The bigger issue is usually transformation: workflow redesign, adoption, training, leadership, benefits tracking, and whether the organisation actually changes how it works. Those factors largely sit with the customer, not the supplier. Read full story (paywalled) Source: HSJ, 16 June 2026
  19. Content Article
    The Patient Safety Incident Response Framework became mandatory for all health services contracted under the NHS Standard Contract, including NHS-funded care delivered by independent healthcare providers, in April 2024. It replaced the Serious Incident (SI) framework. The change in approach to investigations under PSIRF has resulted in some practical challenges to the way in which information and organisational learning evidence is presented to the coroner for inquests. Chaired by Amelia Newbold, Risk Management Lead, this Shared Insights session discussed how the PSIRF and coronial processes can work more effectively together to ensure that coroners receive the information they need for inquests while preserving PSIRF's core principle of fostering a learning culture within healthcare. Bringing together perspectives from across the system, we explored some of the key challenges and, importantly, shared positive and practical examples of how a collaborative approach across both learning and coronial processes can ensure that relevant information is shared effectively.
  20. Community Post
    I am so sorry to hear that you have been subjected to completely unnecessary pain. You are one of thousands that we know about - the tip of the iceberg. “ trial by hysteroscopy “ should have no place in the 21st century, yet instead of improving, gynaecological “ care” appears to be regressing. Your account of being subjected to pain by lovely people is a very familiar one. To avoid the risk of repeating myself, could I refer you to my reply of 18th February to Carrie. It would be very helpful if you could fill in the Campaign Against Painful Hysteroscopy’s survey to record your experience - this is anonymous, and helps us to collect evidence that is frequently denied and / or ignored by hysteroscopists.
  21. News Article
    Worrying health risks and dangerous conditions are widespread across NHS hospitals, clinics and ambulance stations, new research has revealed. A Unison survey of over 19,000 NHS staff exposed workplaces plagued by leaking sewage, rodent infestations, and a lack of clean toilets for both staff and patients. Around one in seven respondents reported vermin, such as rats, in their workplaces over the past year. A similar proportion cited other widespread infestations, including silverfish, ants, bedbugs and cockroaches. The union described its findings as a concerning snapshot of a "dangerous and dilapidated" NHS estate. One in seven polled believe their workplace is unsafe due to the buildings’ poor physical state. The findings, being released at the union’s annual conference in Brighton on Tuesday, include examples of buckets on floors to catch leaking water, sewage leaks, public toilets in hospitals out of order for extended periods and staff toilets described as unusable. Read full story Source: The Independent, 16 June 2026
  22. News Article
    The specialist learning-disability nurse workforce is in “absolute crisis” with the number of specialist nurses falling by a third across the UK since 2009, leaving many vulnerable adults with inadequate care, according to a report by the largest nursing union. The Royal College of Nursing review revealed that the number of learning-disability nurses employed by the NHS has fallen from 7,083 in 2009 to 4,768 in 2026. As a result of these falling numbers, 1.5 million people with learning disabilities were not being provided with their legal right to equitable access to health and care services. This failure in care has mainly been attributed to the chronic lack of specialist learning-disability nurses available across the UK, with this gap expected to widen in the coming years. Only 490 learning-disability nursing students had chosen to study the specialism in the UK, according to the analysis. This was a 40% reduction over the past decade in the number of students accepted on to these courses. Prof Lynn Woolsey, the Royal College of Nursing’s chief officer, said the review’s findings were a “warning that we cannot continue this path where learning-disability nursing is consistently undermined”. “The learning-disability nurse workforce is in absolute crisis, with workforce numbers falling while university student numbers also collapse. Their skills are too vital for this to be allowed to continue,” Woolsey said. She added: “The expertise of learning-disability nurses has been poorly understood, inconsistently recognised, and insufficiently protected within health and care systems. Their contribution is repeatedly undermined and ignored in wide workforce planning and service delivery.” Read full story Source: The Guardian, 16 June 2026 Further reading on the hub: Top picks: Breaking down the barriers faced by people with learning disabilities
  23. Content Article
    Racism and other forms of discrimination not only affect people receiving care, but also many midwifery and nursing professionals who provide it. Everyone deserves to receive equitable, culturally safe, anti-racist, unbiased care. Students and nursing and midwifery professionals deserve to learn and work in psychologically safe environments where discriminatory behaviours and biases are called out, challenged, and not tolerated. Anti-racism is fundamental to patient safety and public protection. The Nursing and Midwifery Council (NMC) anti-racism principles set out some of the ways educators, organisations, registrants and employers can address concerns around inequities in care and racism across health and social care practice, education, and regulation. The principles are designed to: Strengthen cultural safety, curiosity and respect in practice and education Explicitly advance meaningful, sustained anti-racist, bias-aware practice. The principles are organised around four areas. Culture, equity and inclusion. Learning, education and workforce development. Community and person-centred practice. Assurance, accountability and sector improvement.
  24. News Article
    The new NHS chief executive may soon report to a senior civil servant rather than the health secretary, HSJ understands. The downgrade of the NHS CEO role is among several proposals being considered by national officials as they seek to finalise their target structure for the abolition of NHS England, senior sources said. Another proposal, HSJ understands, is that staff in regional teams, who are currently NHSE employees, could be “hosted” by local NHS organisations, rather than become civil servants as part of the Department of Health and Social Care. A year ago, the DHSC issued a “proposed top-level structure for the transformed DHSC” to staff, saying there would be “three permanent secretaries – including the DHSC permanent secretary, the NHS CEO and the chief medical officer”. HSJ understands that this model – which echoed the “three at the top” configuration in the department in the years to 2012 – was agreed between NHSE, the DHSC and 10 Downing Street. As permanent secretaries, all three would report to the health and social care secretary. But several senior national officials are now growing concerned that this agreement is being undermined by separate proposals being developed by DHSC officials. Read full story (paywalled) Source: HSJ, 16 June 2026
  25. Last week
  26. Content Article
    Interviews with leading figures from health and social care. Series 2 Episode 6 Dr Ian Higgison Series 2 Episode 5 Prof Jim Blair Series 2 Episode 4 Andy Burnham - Mayor of Manchester Series 2 Episode 3 Paul Farmer CBE Series 2, Episode 2 Professor Nicola Ranger CEO Royal College of Nursing Series 2 Episode 1 Tom Dolphin Series 1 Episode 15 David Gregson Episode 14 Dr Charlotte Refsum - Tony Blair Institute Episode 13 Rob Webster CBE Episode 12 Sarah Woolnough Episode 11 Sir Jim Mackey, chief executive NHS England Episode 10 - Claire Murdoch Episode 9 Dame Jennifer Dixon Episode 8 Lord Darzi Episode 7 in conversation with Professor Tas Qureshi Episode 6 Dr Penny Dash Episode 5 Dr Bill Kirkup CBE -Learning lessons from past enquiries Episode 4 Jeremy Hunt Episode 3 Sir Andrew Dilnot Episode 2 Paul Johnson Episode 1 The Convert - Richard Meddings, former Chair NHS England
  27. Content Article
    Everyone deserves to learn and work in a safe, respectful environment. The new Breaking the Silence: Sexual Safety for Healthcare Students and Trainees e-learning offers practical steps to speak up safely, set clear boundaries and get the right support. Feel more confident about what’s acceptable, what isn’t, and what to do if you see or experience behaviour that crosses the line. Understand where to raise concerns and how to support a colleague who shares an experience. Whether a student, trainee, educator, or staff member complete the e-learning to strengthen your own wellbeing and professionalism and help build a culture where harassment is not tolerated.  The e-learning is accessed via the NHS learning hub or via the e-Learning for Health platform. Find out more from the attachment below.
  28. Content Article
    This report contains feedback from focus groups the Patients Association ran across six language backgrounds – Arabic, Bengali, Portuguese, Punjabi, Romanian and Urdu – and research on those who speak English as an additional language, highlighting the numerous barriers to care that they face. Some of the barriers highlighted include a need for quality and personalisation in translations, reliance on community members as informal interpreters and medical jargon as a barrier even with interpretation.
  1. Load more activity
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.